Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.8.0.1
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)
9 Months Ended
Sep. 30, 2017
USD ($)
$ / shares
shares
Equity [Abstract]  
Stock option outstanding, beginning balance | shares
Stock option outstanding, granted | shares 93,203,369
Stock option outstanding, cancelled | shares
Stock option outstanding, exercised | shares
Stock option outstanding, ending balance | shares 93,203,369
Stock option outstanding, exercisable | shares 93,931,064
Weighted average exercise price, beginning balance | $ / shares
Weighted average exercise price, granted | $ / shares 0.029
Weighted average exercise price, cancelled | $ / shares
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, ending balance | $ / shares 0.029
Weighted average exercise price, exercisable | $ / shares $ 0.029
Weighted average remaining contractual term (years), outstanding 4 years 3 months 15 days
Weighted average remaining contractual term (years), exercisable 4 years 3 months 15 days
Aggregated intrinsic value, outstanding | $ $ 2,674,937
Aggregated intrinsic value, exercisable | $ $ 2,674,937